A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism. / Turner, Nigel; Lim, Xin Ying; Toop, Hamish D.; Osborne, Brenna; Brandon, Amanda E.; Taylor, Elysha N.; Fiveash, Corrine E.; Govindaraju, Hemna; Teo, Jonathan D.; McEwen, Holly P.; Couttas, Timothy A.; Butler, Stephen M.; Das, Abhirup; Kowalski, Greg M.; Bruce, Clinton R.; Hoehn, Kyle L.; Fath, Thomas; Schmitz-Peiffer, Carsten; Cooney, Gregory J.; Montgomery, Magdalene K.; Morris, Jonathan C.; Don, Anthony S.
I: Nature Communications, Bind 9, 3165, 12.2018.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism
AU - Turner, Nigel
AU - Lim, Xin Ying
AU - Toop, Hamish D.
AU - Osborne, Brenna
AU - Brandon, Amanda E.
AU - Taylor, Elysha N.
AU - Fiveash, Corrine E.
AU - Govindaraju, Hemna
AU - Teo, Jonathan D.
AU - McEwen, Holly P.
AU - Couttas, Timothy A.
AU - Butler, Stephen M.
AU - Das, Abhirup
AU - Kowalski, Greg M.
AU - Bruce, Clinton R.
AU - Hoehn, Kyle L.
AU - Fath, Thomas
AU - Schmitz-Peiffer, Carsten
AU - Cooney, Gregory J.
AU - Montgomery, Magdalene K.
AU - Morris, Jonathan C.
AU - Don, Anthony S.
PY - 2018/12
Y1 - 2018/12
N2 - Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family, are believed to regulate metabolic physiology. Genetic mouse models have established C16 ceramide as a driver of insulin resistance in liver and adipose tissue. C18 ceramide, synthesized by ceramide synthase 1 (CerS1), is abundant in skeletal muscle and suggested to promote insulin resistance in humans. We herein describe the first isoform-specific ceramide synthase inhibitor, P053, which inhibits CerS1 with nanomolar potency. Lipidomic profiling shows that P053 is highly selective for CerS1. Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity, but does not protect against HFD-induced insulin resistance. Our inhibitor therefore allowed us to define a role for CerS1 as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity.
AB - Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family, are believed to regulate metabolic physiology. Genetic mouse models have established C16 ceramide as a driver of insulin resistance in liver and adipose tissue. C18 ceramide, synthesized by ceramide synthase 1 (CerS1), is abundant in skeletal muscle and suggested to promote insulin resistance in humans. We herein describe the first isoform-specific ceramide synthase inhibitor, P053, which inhibits CerS1 with nanomolar potency. Lipidomic profiling shows that P053 is highly selective for CerS1. Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity, but does not protect against HFD-induced insulin resistance. Our inhibitor therefore allowed us to define a role for CerS1 as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity.
U2 - 10.1038/s41467-018-05613-7
DO - 10.1038/s41467-018-05613-7
M3 - Journal article
VL - 9
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 3165
ER -
ID: 291673358